Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting

INTRODUCTION: BCG vaccination reduces all-cause infant mortality in high-mortality settings by more than can be attributed to protection against tuberculosis. This is proposed to result from non-specific protection against non-vaccine targeted (‘off-target’) infections. There is also evidence that B...

Descripción completa

Detalles Bibliográficos
Autores principales: Messina, Nicole L, Gardiner, Kaya, Donath, Susan, Flanagan, Katie, Ponsonby, Anne-Louise, Shann, Frank, Robins-Browne, Roy, Freyne, Bridget, Abruzzo, Veronica, Morison, Clare, Cox, Lianne, Germano, Susie, Zufferey, Christel, Zimmermann, Petra, Allen, Katie J, Vuillermin, Peter, South, Mike, Casalaz, Dan, Curtis, Nigel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924750/
https://www.ncbi.nlm.nih.gov/pubmed/31843845
http://dx.doi.org/10.1136/bmjopen-2019-032844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924750/
https://www.ncbi.nlm.nih.gov/pubmed/31843845
http://dx.doi.org/10.1136/bmjopen-2019-032844

Ejemplares similares